Prescription rule remains unchanged for morning-after pills

Published: 2012-08-31 07:00:00

Updated: 2012-08-31 07:00:00

The Ministry of Health and Welfare and the Korean Food and Drug Administration (KFDA) announced Wednesday the results of their review as well as the reclassification of 504 types of medicine sold in Korea, which will be implemented March 1 next year.

The status quo remains for birth control and morning-after pills, officials said, as the KFDA’s Central Pharmaceutical Affairs Council decided...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.